Outset Medical announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.

Outset Medical plans to begin shipping the updated platform during the second quarter of 2026.

Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 ...

Outset Medical stock jumps after FDA clears next-gen Tablo dialysis system, the first to meet the agency's latest ...

Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis ...

Outset Medical, Inc. (Nasdaq: OM) ('Outset”), a medical technology company pioneering a first-of-its-kind technology to ...

KiiiKiii Unveils *Delulu Pack* with Sharper Gen Z Aesthetic Title track 404 New Era and self-belief message mark groups ...

SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...

SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ...

Detailed price information for Outset Medical Inc (OM-Q) from The Globe and Mail including charting and trades.

Investing.com -- Outset Medical Inc (NASDAQ:OM) stock jumped 9% in premarket trading Tuesday after the medical technology company announced FDA clearance for its next-generation Tablo dialysis ...

For 25 years, Pew Research Center has tracked some of the biggest technological shifts in history. Note: We conducted polls via phone from 2000 to 2021; via web and mail in 2023; and via web, mail and ...